Viz launches AI-powered tool to identify strokes

Viz

With more than 140,000 deaths per year, stroke is the third leading cause of death in the U.S. San Francisco-based startup called Viz is launching an artificial intelligence-backed solution to help tackle this problem.

Backed to the tune of $2.5 million by former Google chief executive Eric Schmidt’s investment firm, Innovation Endeavors, and Yahoo founder Jerry Yang’s AME Ventures — Viz was founded by Chris Mansi and David Golan, who aim to use AI to more rapidly identify stroke victims in order to ensure treatment faster, potentially saving lives along with millions of dollars in medical expenses.

Viz uses machine learning to identify anomalies in brain scans that even physicians have a hard time spotting. This in turn puts the expert neuroscience knowledge in the hands of just about any doctor.

“We’ve been looking for really smart teams that have the right domain expertise about what they’re trying to do,” says Dror Berman, a co-founder of Innovation Endeavors and a director on the Viz board. “Viz is solving a really big problem that no one else is solving, given how hard it is to look into brains scans and the very limited expertise of physicians.”

It is estimated that stroke patients cost the U.S. healthcare system $74 billion in Medicare payments. If recognized on time and being treated properly for stroke, that figure could be radically reduced. And, obviously, that’s what make Viz a promising company to invest in…